Clinical Social Workers in Cooper City, FL Accepting Medicare
8 Clinical Social Workers found. Showing 1 - 8
 Mrs. Rebecca Joy Sam-mccaghren, LCSW LICENSED CLINIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10000 Stirling Rd, 6, Cooper City, FL 33024 Phone: 954-436-8326 Fax: 954-433-0603 |
Ms. Karen Pino, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9900 Stirling Road, Suite 241, Cooper City, FL 33024 Phone: 305-793-7870 |
Mrs. Amy Marie York, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4901 Sw 94th Ave, Cooper City, FL 33328 Phone: 813-786-4308 |
 William John Scheer, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10132 S.w. 49th. Manor, Cooper City, FL 33328 Phone: 954-625-8742 |
Ahuva Shandelman, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10548 Sw 49th Pl, Cooper City, FL 33328 Phone: 845-558-7628 |
Jill Tourville Pinder, MSW, LCSW, CAP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12401 Stirling Rd, Suite 211, Cooper City, FL 33330 Phone: 954-520-0725 Fax: 954-680-2030 |
Brittany Leigh Wolfe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8664 Sw 55th St, Cooper City, FL 33328 Phone: 321-368-3891 |
Mr. Patrick Mobray Mccaghren, LCSW LICENSED CLINIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10000 Stirling Rd, #6, Cooper City, FL 33024 Phone: 954-436-8326 Fax: 954-433-0603 |
News Archive
"Nanovaccine" reverses diabetes
A new study, published online April 8 by Cell Press in the journal Immunity, describes a unique therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease. In addition to providing new insight into diabetes, the research also reveals an aspect of the pathogenesis of the autoimmune response that may provide a therapeutic strategy for multiple autoimmune disorders.
Novel HIV prevention products for women demonstrate safety in clinical studies
Two early clinical studies of novel HIV prevention products for women - the first combination antiretroviral (ARV) vaginal ring and a vaginal film - show the products to be safe and open the door to product improvements that could expand options for women-initiated prevention tools. The results of both studies were presented today at the 21st Conference on Retroviruses and Opportunistic Infections.
Scientists discover new serine protease: NSP4
Neutrophil granulocytes comprise important defences for the immune system. When pathogenic bacteria penetrate the body, they are the first on the scene to mobilise other immune cells via signal molecules, thereby containing the risk. To this end, they release serine proteases - enzymes that cut up other proteins to activate signal molecules. Scientists at the Max Planck Institute of Neurobiology in Martinsried have now discovered a new serine protease: neutrophil serine protease 4, or NSP4.
FibroGen starts patient enrollment in FG-3019 Phase 2 study for idiopathic pulmonary fibrosis treatment
FibroGen, Inc., announced today that patient enrollment has started in a new Phase 2 clinical study of FG-3019 in patients who suffer from idiopathic pulmonary fibrosis.
› Verified 9 days ago
Pharmacists
Dentists
Counselors
Occupational Therapists
Psychologists
Clinical Social Workers